Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MYD88 mutation + CD79B mutation
i
Other names:
CD79B, B-Cell Antigen Receptor Complex-Associated Protein Beta Chain, CD79b Molecule, Immunoglobulin-Associated Beta, Immunoglobulin-Associated B29 Protein, B-Cell-Specific Glycoprotein B29, Ig-Beta, IGB, B29, CD79b Antigen (Immunoglobulin-Associated Beta), CD79B Antigen (Immunoglobulin-Associated Beta), CD79b Antigen, AGM6, MYD88, MYD88 Innate Immune Signal Transduction Adaptor, Myeloid Differentiation Primary Response Protein MyD88, Myeloid Differentiation Primary Response Gene (88), Myeloid D
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4615
;
974
Related biomarkers:
Expression
Mutation
Others
‹
MYD88 overexpression (2)
CD79B expression (1)
MYD88 overexpression (2)
CD79B expression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MYD88 mutation + CD79B mutation
Lymphoma
MYD88 mutation + CD79B mutation
Lymphoma
rituximab + orelabrutinib
Sensitive: C3 – Early Trials
rituximab + orelabrutinib
Sensitive
:
C3
rituximab + orelabrutinib
Sensitive: C3 – Early Trials
rituximab + orelabrutinib
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login